上海谊众11月11日获融资买入699.30万元，融资余额5.86亿元

Core Viewpoint - Shanghai Yizhong's stock experienced a decline of 1.07% on November 11, with a trading volume of 91.72 million yuan, indicating a potential shift in investor sentiment and market dynamics [1] Financing Summary - On November 11, Shanghai Yizhong had a financing buy-in amount of 6.99 million yuan and a financing repayment of 10.00 million yuan, resulting in a net financing outflow of 3.01 million yuan [1] - As of November 11, the total financing and securities lending balance for Shanghai Yizhong was 588 million yuan, with the financing balance at 586 million yuan, accounting for 5.48% of the circulating market value, indicating a high level of financing activity [1] - The financing balance has exceeded the 80th percentile of the past year, suggesting elevated investor interest [1] Securities Lending Summary - On November 11, Shanghai Yizhong repaid 25,630 shares in securities lending, with no shares sold, resulting in a selling amount of 0.00 yuan [1] - The remaining securities lending volume was 23,200 shares, with a securities lending balance of 1.20 million yuan, which is above the 60th percentile of the past year, indicating a relatively high level of short selling activity [1] Company Overview - Shanghai Yizhong Pharmaceutical Co., Ltd. is located at 79 Renqi Road, Fengxian District, Shanghai, established on September 10, 2009, and listed on September 9, 2021 [1] - The company's main business involves the research and industrialization of modified new anti-tumor drugs, with the primary revenue source being the injectable paclitaxel polymer micelle, accounting for 99.84% of total revenue [1] Financial Performance - As of September 30, 2025, Shanghai Yizhong reported a total of 8,053 shareholders, an increase of 23.49% from the previous period, while the average circulating shares per person decreased by 19.02% [2] - For the period from January to September 2025, the company achieved an operating income of 243 million yuan, representing a year-on-year growth of 43.35%, and a net profit attributable to the parent company of 50.66 million yuan, up 46.12% year-on-year [2] - Since its A-share listing, Shanghai Yizhong has distributed a total of 92.23 million yuan in dividends over the past three years [2] Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder of Shanghai Yizhong, holding 2.88 million shares as a new shareholder [2]